357 related articles for article (PubMed ID: 16390788)
1. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
Karateke A; Haliloglu B; Gurbuz A
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
[TBL] [Abstract][Full Text] [Related]
2. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
3. Mutations in coagulation factors in women with unexplained late fetal loss.
Martinelli I; Taioli E; Cetin I; Marinoni A; Gerosa S; Villa MV; Bozzo M; Mannucci PM
N Engl J Med; 2000 Oct; 343(14):1015-8. PubMed ID: 11018168
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
6. Maternal IVS1-401 T allele of the estrogen receptor alpha is an independent predictor of late fetal loss.
Gerhardt A; Scharf RE; Mikat-Drozdzynski B; Krüssel JS; Bender HG; Zotz RB
Fertil Steril; 2006 Aug; 86(2):448-53. PubMed ID: 16753154
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause.
Brenner B; Sarig G; Weiner Z; Younis J; Blumenfeld Z; Lanir N
Thromb Haemost; 1999 Jul; 82(1):6-9. PubMed ID: 10456445
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon.
Zahed LF; Rayes RF; Mahfouz RA; Taher AT; Maarouf HH; Nassar AH
Am J Obstet Gynecol; 2006 Oct; 195(4):1114-8. PubMed ID: 17000243
[TBL] [Abstract][Full Text] [Related]
9. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death.
Sullivan AE; Nelson L; Rice JA; Porter TF; Branch DW; Silver RM
Am J Reprod Immunol; 2005 Jul; 54(1):1-4. PubMed ID: 15948766
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss.
Kupferminc MJ; Peri H; Zwang E; Yaron Y; Wolman I; Eldor A
Acta Obstet Gynecol Scand; 2000 Nov; 79(11):963-7. PubMed ID: 11081681
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
12. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death].
Santoro R; Iannaccaro P; Sottilotta G
Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289
[TBL] [Abstract][Full Text] [Related]
13. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.
Schlembach D; Beinder E; Zingsem J; Wunsiedler U; Beckmann MW; Fischer T
Clin Sci (Lond); 2003 Sep; 105(3):279-85. PubMed ID: 12725641
[TBL] [Abstract][Full Text] [Related]
14. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy. Relation to pregnancy outcomes for mother and fetus.
Abu-Skeen IA; Mohamed AA; Moustafa NN; Badawy ME
Saudi Med J; 2010 Feb; 31(2):123-9. PubMed ID: 20174725
[TBL] [Abstract][Full Text] [Related]
16. The risk of fetal loss in family members of probands with factor V Leiden mutation.
Tormene D; Simioni P; Prandoni P; Luni S; Innella B; Sabbion P; Girolami A
Thromb Haemost; 1999 Oct; 82(4):1237-9. PubMed ID: 10544905
[TBL] [Abstract][Full Text] [Related]
17. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
Yilmazer M; Kurtay G; Sonmezer M; Akar N
Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
[TBL] [Abstract][Full Text] [Related]
19. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
[TBL] [Abstract][Full Text] [Related]
20. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
